NorthWest Biotherapeutics Inc (NWBO)

[rrflyboy]

Highway,
My input is to have your investor friend ask specific questions pertaining to when the HE reimbursement negotiations for DCVAX-L must be completed. I've spent many hours researching the entire text of the German medical act, not just the relevant Section 4b (it is online), the Press section/archive of the Fraunhofer IZI website (they refer to their work with NWBio there) and the website for the InEK, the German LLC referred to in the NWBO March 10, 2014 PR that is supposedly handling the insurance reimbursement negotiations with NWBO over DCVAX-L. I've have yet to find anything discussing a timeline for the completion of the HE insurance reimbursement negotiations. Today, I sent an email, in German, to the "InEK - Institute for the Hospital Remuneration System" info desk asking when the negotiations will be completed. Fyi, their contact info can be found at http://www.g-drg.de/cms/inek_site_en/layout/set/standard/Das_Institut/Kontakt (I used Google Translate to read it, its only in German) - the actual email address for their info desk is [e-mail] .
Almost 6 weeks ago on August 1st I sent an email the the NWBO investors email asking for this same information on the HE reimbursement and have not gotten a reply, here is what I sent:
"Hi,
I’m a shareholder in NWBO and I follow NWBO closely. The March 10, 2014 Press Release indicates the reimbursement amount from the German Sickness Funds will be negotiated “over the coming months.” There is much speculation among investors as to when that decision must be made in the absence of a negotiated agreement for reimbursement amounts. The questions are:
does the German law require a decision be made unilaterally by the government in the absence of an agreed upon reimbursement amount between the company and the german insurers and, if true,
what is the regulatory deadline date for that decision to be made. We keep hearing it is 6 months, but from when? The company has not provided the text of the regulation or stated the timeline requirements of the law/regulation and thus shareholders are left to speculate. Please confirm the requirements of the regulation with regard to the timeline for a decision to be made by the regulators in the absence of a negotiated reimbursement amount with the company."
As others on this MB have pointed out, and I agree, the next leg up for this company will come from a PR giving specific data on the completion of the HE reimbursement from the Germans and/or specific data on the DCVAX-Direct results to date. I've grown weary of LP waving verbal pom-pons without specifics to back it up and the lack of specific data like the HE negotiations investors should have in order to make rational investment decisions on this company.
The good news is Adam Feuerstein hasn't attacked NWBO yet on Twitter - I now follow him on Twitter just for that reason.